U-Neuron Biomedical (ROCO:6973) EV-to-EBITDA : -12.42 (As of May. 27, 2024)

U-Neuron Biomedical EV-to-EBITDA Chart

Competitive Comparison of U-Neuron Biomedical's EV-to-EBITDA

For the Biotechnology subindustry, U-Neuron Biomedical's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U-Neuron Biomedical's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, U-Neuron Biomedical's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where U-Neuron Biomedical's EV-to-EBITDA falls into.

U-Neuron Biomedical EV-to-EBITDA Calculation

U-Neuron Biomedical's EV-to-EBITDA for today is calculated as:

U-Neuron Biomedical's current Enterprise Value is NT$966.88 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U-Neuron Biomedical's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-77.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical  (ROCO:6973) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

U-Neuron Biomedical's PE Ratio for today is calculated as:

U-Neuron Biomedical's share price for today is NT$48.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. U-Neuron Biomedical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-3.775.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

U-Neuron Biomedical EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of U-Neuron Biomedical's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

U-Neuron Biomedical (ROCO:6973) Business Description